The production of Traditional Chinese Medicine (TCM) in China experienced fluctuations over the past decade. From 2013 to 2017, there was a steady increase with compound annual growth rates (CAGR) peaking at 10.36% in 2014 and gradually slowing to 4.15% by 2017. A significant drop occurred in 2018, with production volume falling by 32.48%. This downturn was followed by a modest recovery over the next five years, with overall production increasing from 244.88 ten thousand metric tons in 2020 to 303.94 ten thousand metric tons in 2023, reflecting a CAGR of 3.25% for the five-year period ending in 2023.
Future trends forecast a consistent yet modest growth in TCM production, projected to reach 336.22 ten thousand metric tons by 2028 with a forecasted 5-year CAGR of 1.57%. This indicates a relatively stable and slowly growing market.
Trends to watch for in the future include:
- Potential impacts of regulatory changes in the pharmaceutical sector.
- Rising global demand for natural and alternative medicines.
- Technological advancements in TCM production and standardization.
- Influence of health and wellness trends globally.
- Possible environmental and sustainability challenges.
